Company: NDRA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001654954-25-009643
Chunk: 41

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 1A
Chunk 41
---
 Definition Linkbase (filed herewith)101.LAB XBRL Taxonomy Extension Label Linkbase (filed herewith)101.PRE XBRL Taxonomy Extension Presentation Linkbase (filed herewith)

* Indicates management compensatory plan, contract or arrangement.

** Certain information has been omitted from the exhibit pursuant to Item 601(b)(10) of Regulation S-K.

 25Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 ENDRA LIFE SCIENCES INC.    Date: August 14, 2025By: /s/ Alexander Tokman  Alexander Tokman   Chief Executive Officer and Chairman   (Principal Executive Officer)     ENDRA LIFE SCIENCES INC.    Date: August 14, 2025By:   /s/ Richard Jacroux   Richard Jacroux   Chief Financial Officer   (Principal Financial and Accounting Officer) 

 26